You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: March 29, 2024

TESLASCAN Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


When do Teslascan patents expire, and when can generic versions of Teslascan launch?

Teslascan is a drug marketed by Ic Targets and is included in one NDA.

The generic ingredient in TESLASCAN is mangafodipir trisodium. Additional details are available on the mangafodipir trisodium profile page.

Summary for TESLASCAN
US Patents:0
Applicants:1
NDAs:1
Raw Ingredient (Bulk) Api Vendors: 22
Clinical Trials: 1
DailyMed Link:TESLASCAN at DailyMed
Drug patent expirations by year for TESLASCAN
Recent Clinical Trials for TESLASCAN

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
PledPharma ABPhase 2
Egetis TherapeuticsPhase 2

See all TESLASCAN clinical trials

Anatomical Therapeutic Chemical (ATC) Classes for TESLASCAN

US Patents and Regulatory Information for TESLASCAN

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Ic Targets TESLASCAN mangafodipir trisodium INJECTABLE;INJECTION 020652-001 Nov 26, 1997 DISCN No No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Expired US Patents for TESLASCAN

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Ic Targets TESLASCAN mangafodipir trisodium INJECTABLE;INJECTION 020652-001 Nov 26, 1997 ⤷  Try a Trial ⤷  Try a Trial
Ic Targets TESLASCAN mangafodipir trisodium INJECTABLE;INJECTION 020652-001 Nov 26, 1997 ⤷  Try a Trial ⤷  Try a Trial
Ic Targets TESLASCAN mangafodipir trisodium INJECTABLE;INJECTION 020652-001 Nov 26, 1997 ⤷  Try a Trial ⤷  Try a Trial
Ic Targets TESLASCAN mangafodipir trisodium INJECTABLE;INJECTION 020652-001 Nov 26, 1997 ⤷  Try a Trial ⤷  Try a Trial
Ic Targets TESLASCAN mangafodipir trisodium INJECTABLE;INJECTION 020652-001 Nov 26, 1997 ⤷  Try a Trial ⤷  Try a Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration

International Patents for TESLASCAN

See the table below for patents covering TESLASCAN around the world.

Country Patent Number Title Estimated Expiration
Canada 1218597 SELS COMPLEXES PARAMAGNETIQUES, MODE DE PREPARATION ET UTILISATION DANS LES TECHNIQUES DE DIAGNOSTIC PAR RESONANCE MAGNETIQUE NUCLEAIRE (PARAMAGNETIC COMPLEX SALTS, THEIR PREPARATION, AND THEIR USE IN NMR-DIAGNOSTICS) ⤷  Try a Trial
European Patent Office 0169299 USE OF PARAMAGNETIC COMPLEX SALTS FOR THE PREPARATION OF AGENTS FOR NMR DIAGNOSTICS ⤷  Try a Trial
Israel 100640 ⤷  Try a Trial
South Africa 8205313 ⤷  Try a Trial
Denmark 170461 ⤷  Try a Trial
Hong Kong 55195 Dipyridoxyl phosphate nuclear magnetic resonance imagery contrast agents. ⤷  Try a Trial
Australia 607456 ⤷  Try a Trial
>Country >Patent Number >Title >Estimated Expiration

Supplementary Protection Certificates for TESLASCAN

Patent Number Supplementary Protection Certificate SPC Country SPC Expiration SPC Description
0071564 SPC/GB93/060 United Kingdom ⤷  Try a Trial
0290047 97C0108 Belgium ⤷  Try a Trial PRODUCT NAME: MANGAFODIPIR TRISODIUM (ANHYDROUS) CORRESP. MANGAFODIPIR; REGISTRATION NO/DATE: EU/1/97/040/001 19970522
0290047 C00290047/01 Switzerland ⤷  Try a Trial FORMER REPRESENTANTIVE: A. BRAUN, BRAUN, HERITIER, ESCHMANN AG PATENTANWAELTE, CH
0290047 67/1997 Austria ⤷  Try a Trial PRODUCT NAME: MANGAFODIPIR; REGISTRATION NO/DATE: SG(97)D/3940 19970522
0290047 SPC/GB97/078 United Kingdom ⤷  Try a Trial PRODUCT NAME: MANGAFODIPIR AND PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF, IN PARTICULAR MANGAFODIPIR TRISODIUM; REGISTERED: UK EU/1/97/040/001 19970522; UK EU/1/97/040/002 19970522
>Patent Number >Supplementary Protection Certificate >SPC Country >SPC Expiration >SPC Description

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.